Cogent Biosciences (COGT) Earnings Date, Estimates & Call Transcripts → the most reliable asset on earth is making a comeback (From DTI) (Ad) Free cogt Stock Alerts $6.72 +0.20 (+3.07%) (As of 03/28/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 14EstimatedActual EPS (Feb. 26) -$0.63 Missed By -$0.08 Consensus EPS (Feb. 26) -$0.55 Get Cogent Biosciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for COGT and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCOGT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.COGT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaCrypto Market Preps For Trillions Worth of Inflows! Bitcoin is rapidly approaching new ALL-TIME HIGHS… The market is buzzing after recent approval of spot Bitcoin exchange-traded funds (ETF). Top analysts predict these ETFs will attract trillions of dollars worth of inflows over the next few years… And as Bitcoin rallies, we could see other smaller coins rise to heights never seen before.Click to join the Crypto Community Summit Free Online Event Cogent Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243($0.55)($0.51)($0.53)Q2 20243($0.53)($0.43)($0.49)Q3 20243($0.56)($0.40)($0.49)Q4 20243($0.56)($0.37)($0.49)FY 202412($2.20)($1.71)($1.99)Q1 20251($0.36)($0.36)($0.36)Q2 20251($0.35)($0.35)($0.35)Q3 20251($0.35)($0.35)($0.35)Q4 20251($0.34)($0.34)($0.34)FY 20254($1.40)($1.40)($1.40)COGT Earnings Date and InformationCogent Biosciences last issued its earnings results on February 26th, 2024. The technology company reported ($0.63) EPS for the quarter, missing the consensus estimate of ($0.55) by $0.08. Cogent Biosciences has generated ($2.40) earnings per share over the last year (($2.40) diluted earnings per share). Earnings for Cogent Biosciences are expected to grow in the coming year, from ($1.87) to ($1.65) per share. Cogent Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.Read More Cogent Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/14/2024Estimated)------- 2/26/2024Q4 2023($0.55)($0.63)($0.08)($0.63)--11/2/2023Q3 2023($0.50)($0.64)($0.14)($0.64)--8/8/2023Q2 2023($0.53)($0.59)($0.06)($0.59)--5/9/2023Q1 2023($0.58)($0.54)+$0.04($0.54)--3/14/2023Q4 2022($0.50)($0.56)($0.06)($0.56)--11/14/2022Q3 2022($0.51)($0.50)+$0.01($0.50)-- Get the Latest News and Ratings for COGT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cogent Biosciences and its competitors with MarketBeat's FREE daily newsletter. 8/9/2022Q2 2022($0.64)($0.71)($0.07)($0.71)--5/10/2022Q1 2022($0.53)($0.68)($0.15)($0.68)-- 3/15/2022Q4 2021($0.55)($0.61)($0.06)($0.61)--11/10/2021Q3($0.4060)($0.48)($0.0740)($0.48)--8/15/2021Q2 2021($0.36)($0.43)($0.07)($0.43)--5/11/2021Q1 2021($0.28)($0.34)($0.06)($0.34)-- Cogent Biosciences Earnings - Frequently Asked Questions When is Cogent Biosciences's earnings date? Cogent Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on COGT's earnings history. Did Cogent Biosciences beat their earnings estimates last quarter? In the previous quarter, Cogent Biosciences (NASDAQ:COGT) missed the analysts' consensus estimate of ($0.55) by $0.08 with a reported earnings per share (EPS) of ($0.63). Learn more on analysts' earnings estimate vs. COGT's actual earnings. How much profit does Cogent Biosciences generate each year? Cogent Biosciences (NASDAQ:COGT) has a recorded net income of -$192.41 million. COGT has generated -$2.40 earnings per share over the last four quarters. What is Cogent Biosciences's EPS forecast for next year? Cogent Biosciences's earnings are expected to grow from ($1.87) per share to ($1.65) per share in the next year. More Earnings Resources from MarketBeat Related Companies: SLN Earnings Results TYRA Earnings Results AVTE Earnings Results PRAX Earnings Results WVE Earnings Results ELVN Earnings Results SVRA Earnings Results APLT Earnings Results BCYC Earnings Results PHAR Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Lululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later?Is Roku worth a second look after the earnings panic selloff?Dell Technologies breaks out ahead of earnings releaseNovavax’s dispute resolution and upcoming earnings callImpinj stock surges on strong earnings and guidanceAirbnb stock bulls just went all in before earnings This page (NASDAQ:COGT) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cogent Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.